Stock Analiz

EoCene Ltd. EOCN

Biotechnology: Pharmaceutical Preparations · IPO 2014 · data as of November 13, 2026

$2.48Market cap $3M
Open the interactive analysis →

EoCene Ltd. (EOCN) is a healthcare company listed in the US with a market value of about $3M.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is financial health (4/5); the weakest is value (0/5).

About EoCene

EoCene is listed in the US and classified in biotechnology: pharmaceutical preparations, IPO year 2014. It was profitable in 0 of the last 10 years in our data.

Score: 0.8 / 5

Value0/5
Future growth0/5
Track record0/5
Financial health4/5
Shareholder returns0/5

Checks passed

  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S—
P/B0.2
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)—
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)-60.3%
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)—
ROIC (5-yr avg.)—
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal year2025202420232022202120202019201820172016
Revenue—————$0$0$2M$1M$467000
Net income-$10M-$8M-$7M-$18M-$32M-$29M-$20M-$10M-$12M-$17M
Free cash flow———-$19M-$33M-$26M-$15M-$9M-$12M-$12M
EPS (diluted)$-9.90$-7.22$-6.64$-17.15$-31.17$-27.62$-19.64$-9.46$-11.81$-16.28
Net margin———————-483.6%-1133.5%-3630.2%
ROIC—————-67.8%-31.8%-9.6%-78.3%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does EoCene pay a dividend?

Not currently.

Is EoCene a good stock to buy?

We do not give buy or sell advice. EoCene scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.